SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-23-000620
Filing Date
2023-07-31
Accepted
2023-07-31 17:21:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 ovid13g-07242023.htm SC 13G 119663
  Complete submission text file 0001013594-23-000620.txt   121155
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90350 | Film No.: 231128498
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155
Business Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155 212-702-8644
Madison Avenue Partners, LP (Filed by) CIK: 0001801265 (see all company filings)

IRS No.: 320567414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G